Pediatria Polska

Abstract

2/2026 vol. 101
Case report

When rarity meets complexity - Schimke immuno-osseous dysplasia with nephrotic syndrome: a 15-year longitudinal case report

  1. Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland

  2. Foundation of Prof. Jerzy Sadowski HEART for KNOWLEDGE, Cracow, Poland

  3. Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Cracow, Poland

Pediatr Pol 2026; 101 (2): 198-204

Online publish date: 2026/06/30
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Schimke immuno-osseous dysplasia (SIOD) is an exceptionally rare autosomal recessive disorder caused by pathogenic variants in the SMARCAL1 gene and characterised by spondyloepiphyseal dysplasia, immuno- deficiency, and progressive renal disease, often presenting as steroid-resistant nephrotic syndrome. Fewer than 100 cases have been reported worldwide. This manuscript describes a male patient with genetically confirmed SIOD, monitored age 4.5–19 years. Early features included growth failure, hyperpigmentation, skeletal abnormalities, moderate T-cell lymphopaenia, and biopsy-proven focal segmental glomerulosclerosis. In adolescence, the disease transitioned to a severe phenotype with end-stage renal disease, recurrent infections, bone marrow failure, and Evans syndrome, reflecting profound immune dysregulation. Despite multidisciplinary management, including renal-replacement therapy and individualised immunological care, the patient’s condition progressively deteriorated and he ultimately died from multi-organ failure. This long-term observation illustrates the evolving natural history of SIOD and the shift from renal disease in childhood to combined immunodeficiency and haematological complications in adolescence.

Share
without publication fees
without publication fees